The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Do we need adjuvant therapy in rectal cancer with complete pathologic response (ypT0N0) after induction chemoradiation and laparoscopic mesorectal excision?
Verónica Pereira
No relevant relationships to disclose
Aarón Sosa
No relevant relationships to disclose
Óscar Reig
No relevant relationships to disclose
Iván Victoria
No relevant relationships to disclose
Luis Roberto Féliz
No relevant relationships to disclose
Juan Ramón Ayuso
No relevant relationships to disclose
Josep Antoni Bombí
No relevant relationships to disclose
Antoni Castells
No relevant relationships to disclose
Carles Conill
No relevant relationships to disclose
Miriam Cuatrecasas
No relevant relationships to disclose
Salvadora Delgado
No relevant relationships to disclose
Gloria Fernández-Esparrach
No relevant relationships to disclose
Àngels Ginés
No relevant relationships to disclose
Antonio Lacy
No relevant relationships to disclose
Rosa Miquel
No relevant relationships to disclose
Mario Pagés
No relevant relationships to disclose
Estela Pineda
No relevant relationships to disclose
Xabier Garcia-Albeniz
No relevant relationships to disclose
Rosa Gallego
No relevant relationships to disclose
Juan Maurel
No relevant relationships to disclose